Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Xometry Inc (NASDAQ:XMTR)’s stock reached a 52-week high of 47.56 USD, marking a significant milestone for the $2.4 billion market cap company. According to InvestingPro data, analysts maintain a bullish outlook with price targets ranging from $40 to $55. This achievement reflects a robust 1-year change of 157.92%, showcasing a remarkable upward trajectory in its stock performance. The company’s growth over the past year has been noteworthy, with revenue growing at 20.19% and four analysts revising earnings upward for the upcoming period. The new 52-week high underscores the confidence investors have in Xometry’s potential for continued expansion and success in the competitive marketplace. Based on InvestingPro’s Fair Value analysis, the stock appears to be trading above its intrinsic value, though subscribers can access 10 additional exclusive ProTips and comprehensive financial metrics for deeper analysis.
In other recent news, Xometry Inc. has reported strong second-quarter results for 2025, significantly surpassing earnings expectations. The company achieved an earnings per share of $0.09, more than doubling the forecast of $0.0439, resulting in a 105.01% surprise. Revenue also exceeded expectations, reaching $163 million compared to the anticipated $156.49 million, marking a 3.87% surprise. Following these results, UBS raised its price target for Xometry to $40, maintaining a Neutral rating. Additionally, Citizens JMP increased its price target to $50, citing the company’s financial performance as exceeding the high end of guidance. JPMorgan also raised its target to $55, highlighting Xometry’s marketplace revenue growth of 26% year-over-year, which surpassed management’s guidance. The company showed strong performance across U.S. enterprises, international markets, and various verticals. These developments reflect recent positive momentum for Xometry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.